The dysregulation of Fe, Cu, and Zn plays a documented role in AD, and this dysregulation could be linked to other AD pathologies, including Aβ aggregation and tau hyperphosphorylation [6]. The gene discussed is MAPT; the disease is Alzheimer disease.